[{"address1": "9310 Athena Circle", "address2": "Suite 300", "city": "LA Jolla", "state": "CA", "zip": "92037", "country": "United States", "phone": "347-897-5988", "website": "https://turnstonebio.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Turnstone Biologics Corp., a clinical stage biotechnology company, focuses on developing medicines to treat and cure patients with solid tumors. The company's lead product includes TIDAL-01 that is in Phase 1 clinical trials for the treatment of breast cancer, colorectal cancer, and uveal melanoma, as well as an investigator sponsored trial to treat cutaneous and non-cutaneous melanomas. It is also developing TIDAL-02, which is in preclinical development for the treatment of solid tumors. The company was founded in 2014 and is based in LA Jolla, California.", "fullTimeEmployees": 94, "companyOfficers": [{"maxAge": 1, "name": "Dr. Sammy J. Farah M.B.A., Ph.D.", "age": 51, "title": "President, CEO & Director", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": 678512, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Venkat  Ramanan Ph.D.", "age": 54, "title": "Chief Financial Officer", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": 346132, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael F. Burgess M.D., MBChB, Ph.D.", "age": 59, "title": "Interim Chief Medical Officer & Executive Director", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": 212690, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Saryah  Azmat", "age": 34, "title": "Chief Business Officer", "yearBorn": 1989, "fiscalYear": 2022, "totalPay": 479729, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Vijay  Chiruvolu M.B.A., Ph.D.", "age": 61, "title": "Interim Chief Technology Officer", "yearBorn": 1962, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stewart  Abbot Ph.D.", "age": 56, "title": "Chief Scientific Officer", "yearBorn": 1967, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 3.08, "open": 3.14, "dayLow": 3.005, "dayHigh": 3.47, "regularMarketPreviousClose": 3.08, "regularMarketOpen": 3.14, "regularMarketDayLow": 3.005, "regularMarketDayHigh": 3.47, "forwardPE": -0.94617563, "volume": 92587, "regularMarketVolume": 92587, "averageVolume": 160750, "averageVolume10days": 202750, "averageDailyVolume10Day": 202750, "bid": 3.34, "ask": 3.46, "bidSize": 100, "askSize": 100, "marketCap": 77130952, "fiftyTwoWeekLow": 1.625, "fiftyTwoWeekHigh": 13.2, "priceToSalesTrailing12Months": 2.5923755, "fiftyDayAverage": 2.9117, "twoHundredDayAverage": 4.5596156, "currency": "USD", "enterpriseValue": -28295130, "profitMargins": -1.76174, "floatShares": 14037126, "sharesOutstanding": 23093100, "sharesShort": 392146, "sharesShortPriorMonth": 361772, "sharesShortPreviousMonthDate": 1706659200, "dateShortInterest": 1709164800, "sharesPercentSharesOut": 0.017, "heldPercentInsiders": 0.11349, "heldPercentInstitutions": 0.67177004, "shortRatio": 2.52, "shortPercentOfFloat": 0.0242, "bookValue": 4.932, "priceToBook": 0.67721003, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -52475000, "trailingEps": -2.27, "forwardEps": -3.53, "enterpriseToRevenue": -0.951, "enterpriseToEbitda": 0.629, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "TSBX", "underlyingSymbol": "TSBX", "shortName": "Turnstone Biologics Corp.", "longName": "Turnstone Biologics Corp.", "firstTradeDateEpochUtc": 1689946200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "e04a4e6f-b2cf-301c-a72a-71f7773d1083", "gmtOffSetMilliseconds": -14400000, "currentPrice": 3.34, "targetHighPrice": 20.0, "targetLowPrice": 6.0, "targetMeanPrice": 13.0, "targetMedianPrice": 13.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 109105000, "totalCashPerShare": 4.725, "ebitda": -44953000, "totalDebt": 3679000, "quickRatio": 8.357, "currentRatio": 9.085, "totalRevenue": 29753000, "debtToEquity": 3.23, "revenuePerShare": 4.599, "operatingCashflow": -70156000, "grossMargins": -1.02427, "ebitdaMargins": -1.5108701, "operatingMargins": -1.6225901, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-03-22"}]